Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
[European journal of nuclear medicine and molecular imaging · 2026
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors at 2 institutions in 1 country.
Jacopo MansoEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.ORCID 0000-0003-2403-4339
Loris BertazzaEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.
Susi BarolloEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.ORCID 0000-0002-5821-2693
Alberto MondinEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.
Simona CensiEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.ORCID 0000-0001-6946-9673
Sofia CarducciEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.
Alfonso Massimiliano FerraraFamilial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.ORCID 0000-0001-5835-1709
Isabella Merante BoschinEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.
Stefania ZovatoFamilial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
Francesca SchiaviFamilial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
Michele GregianinNuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, 31100 Treviso, Italy.
Gianmaria PennelliSurgical Pathology and Cytopathology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.
Maurizio IacoboneDepartment of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), Padua University, 35121 Padua, Italy.ORCID 0000-0002-6057-4642
Caterina MianEndocrinology Unit, Department of Medicine (DIMED), Padua University, 35121 Padua, Italy.ORCID 0000-0003-2615-8001
University of Padua · ITIstituto Oncologico Veneto · IT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Pheochromocytoma (Pheo) is a tumor derived from chromaffin cells. It can be studied using 18F-dihydroxyphenylalanine (DOPA)-positron emission tomography (PET) due to its overexpression of L-type amino acid transporters (LAT1 and LAT2). The oncogenic pathways involved are still poorly understood. This study examined the relationship between
Indexed as
Adaptor Proteins, Signal TransducingAdrenal Gland NeoplasmsAdultAgedAged, 80 and overDihydroxyphenylalanineFemaleGene Expression Regulation, NeoplasticHumansLarge Neutral Amino Acid-Transporter 1MaleMicroRNAsMiddle AgedNorepinephrinePhenylethanolamine N-MethyltransferasePheochromocytomaAdaptor Proteins, Signal TransducingDihydroxyphenylalaninefluorodopa F 18Large Neutral Amino Acid-Transporter 1LAT2 protein, humanMicroRNAsMIRN375 microRNA, humanNorepinephrinePhenylethanolamine N-MethyltransferaseSLC7A5 protein, human18F-dihydroxyphenylalanineL-type amino acid transportermicroRNAmiR-375pheochromocytoma
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications. · full record | OpenQuestion